BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
CV Therapeutics is defunct.

Fate: Acquired by Gilead April 2009, $1.4B


------------------
If you believe any of this information is incorrect, please let us know.